Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Anna E. Lokshin"'
Autor:
Anna E. Lokshin, Denise Prosser, Liudmila Velikokhatnaya, Adele Marrangoni, Aleksey Lomakin, Brian M. Nolen
Supplementary Tables S1-S5. Supplementary Table S1. Histological breakdown of benign controls. Supplementary Table S2. Urine biomarker levels in patients diagnosed with tuberculosis, NSCLC and controls. Supplementary Table S3. Urine biomarkers associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03294a503d616e5d7c0b7066f1a1cf35
https://doi.org/10.1158/1940-6207.22525664.v1
https://doi.org/10.1158/1940-6207.22525664.v1
Autor:
Nicole Urban, Claire S. Zhu, Zhen Zhang, David C. Ward, Sudhir Srivastava, Patrick M. Sluss, Steven J. Skates, Nathalie Scholler, Mark D. Thornquist, Paul F. Pinsky, Christos Patriotis, Gil Mor, Martin W. McIntosh, Karen H. Lu, Anna E. Lokshin, Patricia Hartge, Andrew K. Godwin, Eleftherios P. Diamandis, Christine D. Berg, Robert C. Bast, Daniel W. Cramer
Establishing a cancer screening biomarker's intended performance requires “phase III” specimens obtained in asymptomatic individuals before clinical diagnosis rather than “phase II” specimens obtained from symptomatic individuals at diagnosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf1e70b162e8cd9fbba21a5004249ba5
https://doi.org/10.1158/1940-6207.c.6544857
https://doi.org/10.1158/1940-6207.c.6544857
Autor:
Nicole Urban, Claire S. Zhu, Zhen Zhang, David C. Ward, Sudhir Srivastava, Patrick M. Sluss, Steven J. Skates, Nathalie Scholler, Mark D. Thornquist, Paul F. Pinsky, Christos Patriotis, Gil Mor, Martin W. McIntosh, Karen H. Lu, Anna E. Lokshin, Patricia Hartge, Andrew K. Godwin, Eleftherios P. Diamandis, Christine D. Berg, Robert C. Bast, Daniel W. Cramer
Perspectives on This Article from Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0327c80f36bfd0572b80a18ce723774d
https://doi.org/10.1158/1940-6207.22525686.v1
https://doi.org/10.1158/1940-6207.22525686.v1
Autor:
Anna E. Lokshin, Denise Prosser, Liudmila Velikokhatnaya, Adele Marrangoni, Aleksey Lomakin, Brian M. Nolen
The early detection of lung cancer has the potential to greatly impact disease burden through the timely identification and treatment of affected individuals at a manageable stage of development. The insufficient specificity demonstrated by currently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a7cbf1eb56c3c2db202d138583458a4
https://doi.org/10.1158/1940-6207.c.6544844
https://doi.org/10.1158/1940-6207.c.6544844
Autor:
Christine D. Berg, Saundra S. Buys, Sudhir Srivastava, Christos Patriotis, Adele M. Marrangoni, Karen H. Lu, Nathalie Scholler, Patrick M. Sluss, Eric T. Fung, Aleksey Lomakin, James T. Symanowski, David C. Ward, Zhen Zhang, Allison Vitonis, Steven J. Skates, Martin W. McIntosh, Anna E. Lokshin, Lee E. Moore, Robert C. Bast, Gil Mor, Nicole Urban, Ruth M. Pfeiffer, Patricia Hartge, David F. Ransohoff, Daniel W. Cramer, Paul F. Pinsky, Claire S. Zhu
A panel of biomarkers may improve predictive performance over individual markers. Although many biomarker panels have been described for ovarian cancer, few studies used prediagnostic samples to assess the potential of the panels for early detection.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5efdfd15abacb677fe17610c36b679fb
https://doi.org/10.1158/1940-6207.c.6544599
https://doi.org/10.1158/1940-6207.c.6544599
Autor:
Christine D. Berg, Saundra S. Buys, Sudhir Srivastava, Christos Patriotis, Adele M. Marrangoni, Karen H. Lu, Nathalie Scholler, Patrick M. Sluss, Eric T. Fung, Aleksey Lomakin, James T. Symanowski, David C. Ward, Zhen Zhang, Allison Vitonis, Steven J. Skates, Martin W. McIntosh, Anna E. Lokshin, Lee E. Moore, Robert C. Bast, Gil Mor, Nicole Urban, Ruth M. Pfeiffer, Patricia Hartge, David F. Ransohoff, Daniel W. Cramer, Paul F. Pinsky, Claire S. Zhu
Perspectives on This Article from A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ef42eb78d3a5eef0b36c34e0a3de94b
https://doi.org/10.1158/1940-6207.22525149
https://doi.org/10.1158/1940-6207.22525149
Autor:
Christine D. Berg, Saundra S. Buys, Sudhir Srivastava, Christos Patriotis, Adele M. Marrangoni, Karen H. Lu, Nathalie Scholler, Patrick M. Sluss, Eric T. Fung, Aleksey Lomakin, James T. Symanowski, David C. Ward, Zhen Zhang, Allison Vitonis, Steven J. Skates, Martin W. McIntosh, Anna E. Lokshin, Lee E. Moore, Robert C. Bast, Gil Mor, Nicole Urban, Ruth M. Pfeiffer, Patricia Hartge, David F. Ransohoff, Daniel W. Cramer, Paul F. Pinsky, Claire S. Zhu
Supplementary Materials from A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::331c0cc2086b8e679b5458911c6cfcac
https://doi.org/10.1158/1940-6207.22525146.v1
https://doi.org/10.1158/1940-6207.22525146.v1
Autor:
Paul D. Lampe, Sunil R. Hingorani, Ross L. Prentice, Anna E. Lokshin, Christopher I. Li, Yuzheng Zhang, Justin E. Mirus
Purpose: Pancreatic ductal adenocarcinoma (PDA) is the fourth leading cause of cancer-related death in the United States, and its incidence is on the rise. Advanced disease is nearly uniformly lethal, emphasizing the need to identify PDA at its earli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::304790357543b00b008c9933e3faca1b
https://doi.org/10.1158/1078-0432.c.6524871
https://doi.org/10.1158/1078-0432.c.6524871
Autor:
Anna E. Lokshin, William E. Grizzle, David C. Whitcomb, Douglas P. Landsittel, Christopher J. Langmead, Selwyn M. Vickers, John D. Christein, Juan P. Arnoletti, Eric Elton, Michael Goldberg, Mohamad A. Eloubeidi, Peter J. Allen, Herbert J. Zeh, Brian M. Nolen, Randall E. Brand
CCR Translation for This Article from Serum Biomarker Panels for the Detection of Pancreatic Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b05d99a61fa15cee7d60d70f97b3f29
https://doi.org/10.1158/1078-0432.22441672.v1
https://doi.org/10.1158/1078-0432.22441672.v1
Autor:
Anna E. Lokshin, William E. Grizzle, David C. Whitcomb, Douglas P. Landsittel, Christopher J. Langmead, Selwyn M. Vickers, John D. Christein, Juan P. Arnoletti, Eric Elton, Michael Goldberg, Mohamad A. Eloubeidi, Peter J. Allen, Herbert J. Zeh, Brian M. Nolen, Randall E. Brand
Purpose: Serum–biomarker based screening for pancreatic cancer could greatly improve survival in appropriately targeted high-risk populations.Experimental Design: Eighty-three circulating proteins were analyzed in sera of patients diagnosed with pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::980dda44e0bef7ab8b5feb0cf2731f58
https://doi.org/10.1158/1078-0432.c.6518647.v1
https://doi.org/10.1158/1078-0432.c.6518647.v1